Characterisation of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-2018
暂无分享,去创建一个
K. Bowker | A. MacGowan | M. Avison | J. Findlay | V. Gould | O. M. Williams | P. North | A. Macgowan | O. Williams
[1] A. Birgy,et al. Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study , 2019, Antimicrobial Agents and Chemotherapy.
[2] C. Torres,et al. Adherent/invasive Escherichia coli (AIEC) isolates from asymptomatic people: new E. coli ST131 O25:H4/H30-Rx virotypes , 2018, Annals of Clinical Microbiology and Antimicrobials.
[3] P. Aylin,et al. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study. , 2018, International journal of antimicrobial agents.
[4] J. Schrenzel,et al. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe , 2018, The Journal of antimicrobial chemotherapy.
[5] D. Lecky,et al. CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014 , 2018, The Journal of antimicrobial chemotherapy.
[6] R. Lyons,et al. Risk factors for Escherichia coli bacteraemia: a population-based case-control study , 2017, The Lancet.
[7] F. Hansen,et al. Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark , 2017, BMC Infectious Diseases.
[8] P. Hawkey,et al. Global epidemiology of CTX-M &bgr;-lactamases: temporal and geographical shifts in genotype , 2017, The Journal of antimicrobial chemotherapy.
[9] J. Pitout,et al. Escherichia coli ST131: a multidrug-resistant clone primed for global domination , 2017, F1000Research.
[10] G. Peirano,et al. Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene , 2016, Emerging infectious diseases.
[11] N. Woodford,et al. Clonal expansion of Escherichia coli ST38 carrying a chromosomally integrated OXA-48 carbapenemase gene. , 2016, Journal of medical microbiology.
[12] Jianzhong Shen,et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. , 2015, The Lancet. Infectious diseases.
[13] J. Wain,et al. Rapid Identification of Major Escherichia coli Sequence Types Causing Urinary Tract and Bloodstream Infections , 2014, Journal of Clinical Microbiology.
[14] Torsten Seemann,et al. Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..
[15] D. Mevius,et al. Chromosomal location of blaCTX-M genes in clinical isolates of Escherichia coli from Germany, The Netherlands and the UK. , 2014, International journal of antimicrobial agents.
[16] Ole Lund,et al. In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing , 2014, Antimicrobial Agents and Chemotherapy.
[17] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[18] Nicola K. Petty,et al. Global dissemination of a multidrug resistant Escherichia coli clone , 2014, Proceedings of the National Academy of Sciences.
[19] E. Denamur,et al. Virulence Patterns in a Murine Sepsis Model of ST131 Escherichia coli Clinical Isolates Belonging to Serotypes O25b:H4 and O16:H5 Are Associated to Specific Virotypes , 2014, PloS one.
[20] L. Price,et al. Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010 , 2013, Antimicrobial Agents and Chemotherapy.
[21] J. Campos,et al. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. , 2013, The Journal of antimicrobial chemotherapy.
[22] S. Rasmussen,et al. Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.
[23] Sergey I. Nikolenko,et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..
[24] P. Hawkey,et al. High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. , 2012, The Journal of antimicrobial chemotherapy.
[25] R. Zbinden,et al. Detection of AmpC Beta-Lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic Analysis , 2011, Journal of Clinical Microbiology.
[26] N. Perna,et al. progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement , 2010, PloS one.
[27] D. Mangin. Urinary tract infection in primary care , 2010, BMJ : British Medical Journal.
[28] A. Marchese,et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. , 2009, International journal of antimicrobial agents.
[29] E. Denamur,et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. , 2008, The Journal of antimicrobial chemotherapy.
[30] F. Baquero,et al. Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.
[31] J. Blanco,et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.
[32] T. Walsh,et al. Occurrence and current frequency of CTX-M-type beta-lactamases from a regional hospital in the South West of England. , 2007, The Journal of antimicrobial chemotherapy.
[33] F. Baquero,et al. Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline , 2006, Antimicrobial Agents and Chemotherapy.
[34] Daniel Falush,et al. Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.
[35] L. Nicolle. Epidemiology of urinary tract infections , 2002 .
[36] Betsy Foxman,et al. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.
[37] N. Caroff,et al. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. , 2000, The Journal of antimicrobial chemotherapy.
[38] N. Woodford,et al. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. , 2006, The Journal of antimicrobial chemotherapy.
[39] G. Kahlmeter. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. , 2003, The Journal of antimicrobial chemotherapy.